Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 90
  • Start Date: March 19, 2021
Prevalence and Characteristics of Alterations in Olfactory and Taste Function in Patients With Cardiac Amyloidosis and Nutritional Impact: Multicenter Cross-sectional Study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug, Biological
  • Participants: 25
  • Start Date: March 15, 2021
Slow-Go Strategy for High Risk AL Amyloidosis: Isatuximab for Upfront Therapy
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 40
  • Start Date: March 2021
Efficacy of Daratumumab Combined With Bortezomib and Dexamethasone in Patients With Mayo 04 Stage III Light Chain Amyloidosis: a Prospective Phase II Clinical Trial
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 35
  • Start Date: February 26, 2021
A Phase 2 Study of Belantamab Mafodotin in Patients With Relapsed or Refractory AL Amyloidosis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Dietary Supplement
  • Participants: 20
  • Start Date: February 1, 2021
Effect of Psyllium (Plantago Ovata) on Digestive Disorders in Familial Amyloidosis
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 21
  • Start Date: February 2021
Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 200
  • Start Date: January 1, 2021
Cardiac Amyloidosis in Spinal Stenosis: the CASS-study
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 4
  • Intervention Type: Combination Product
  • Participants: 70
  • Start Date: January 1, 2021
Ultrasound Therapy In Cardiac Amyloidosis
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Drug
  • Participants: 20
  • Start Date: December 31, 2020
Pregnancy Surveillance Program of Women and Infants Exposed to TEGSEDI During Pregnancy
Showing 1-12 of 127